Institutionals Holders Overview For Dynavax Technologies Corporation (DVAX)

Dynavax Technologies Corporation (NASDAQ:DVAX) is at least 295.95% than its current record low price of $3.70. There was a -6.98% decline on 01/16/2018 that led the price to move at $14.65. At recent session, the prices were hovering between $14.65 and $15.775. This company shares are 104.78% off its target price of $30 and the current market capitalization stands at $863.76M. The recent change has given its price a -22.04% deficit over SMA 50 and -40.08% deficit over its 52-week high. The stock witnessed -22.89% declines, -33.11% declines and 51.03% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found DVAX’s volatility during a week at 6.75% and during a month it has been found around 5.2%.

Dynavax Technologies Corporation (DVAX) Top Holders

Institutional investors currently hold around $673 million or 72.1% in DVAX stock. Look at its top three institutional owners. Blackrock Inc. owns $60.59 million in Dynavax Technologies Corporation, which represents roughly 7.01% of the company’s market cap and approximately 9% of the institutional ownership. Similar statistics are true for the second largest owner, State Street Corp, which owns 3,073,692 shares of the stock are valued at $48.41 million. The third largest holder is Gmt Capital Corp, which currently holds $48.16 million worth of this stock and that ownership represents nearly 5.58% of its market capitalization.

Dynavax Technologies Corporation 13F Filings

At the end of 09/30/2017 reporting period, 73 institutional holders increased their position in Dynavax Technologies Corporation (NASDAQ:DVAX) by some 15,158,971 shares, 45 decreased positions by 8,427,893 and 18 held positions by 19,165,307. That puts total institutional holdings at 42,752,171 shares, according to SEC filings. The stock grabbed 27 new institutional investments totaling 3,526,128 shares while 17 institutional investors sold out their entire positions totaling 4,672,226 shares.

Dynavax Technologies Corporation (NASDAQ:DVAX) Insider Trades

Multiple company employees have indulged in significant insider trading. Dynavax Technologies Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Vice President Johnson David Louis has sold 3,092 shares of Dynavax Technologies Corporation (DVAX) in trading session dated Jan. 04, 2018. These shares are worth $57,511 and were traded at $18.6 each. The SEC filing shows that Coffman Robert performed a sale of 7,500 shares. The Senior Vice President disposed these shares by way of transaction on Dec. 13, 2017. The company’s shares were given away at $18.9 per share worth to an income of some $141,750 on account of Coffman Robert.

Vice President, Janssen Robert, purchased 6,000 common shares of Dynavax Technologies Corporation (DVAX) in the open market. In a transaction dated Jan. 24, 2017, the shares were bought at an average price of $4.04, giving away a sum of $24,240. After this purchase, 12,048 common shares of DVAX are directly owned by the insider, with total stake valued at $176,503.

In the transaction dated Jun. 28, 2016, the great number of shares acquired came courtesy the Vice President; Janssen Robert added a total of 1,452 shares at an average price of $13.68, amounting to approximately $19,863. The insider now directly owns 6,048 shares worth $88,603.

Dynavax Technologies Corporation (DVAX) Analyst Guide

Several analysts have released their opinion on Dynavax Technologies Corporation (NASDAQ:DVAX), with 4 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.2 average brokerage recommendation.

Previous articleKaryopharm Therapeutics Inc. (KPTI) Stock Ownership And Insider News
Next articleTop Energy XXI Gulf Coast, Inc. (EXXI) Shareholders For 09/30/2017